Key Highlights

  • The Market Price was $341.23 on 6 November 2026, up $0.03 or 0.01 per cent on the session.
  • Pharmaceuticals account for 33.20 per cent of the portfolio, the largest sub-sector.
  • Eli Lilly is the largest holding at 12.93 per cent.
  • The expense ratio is 0.09 per cent a year, and the fund holds 412 stocks.

The Vanguard Health Care ETF (NYSE:VHT) gives investors exposure to U.S. companies providing medical products, pharmaceuticals, biotechnology, healthcare services and related technology. As at 6 November 2026, the market price was $341.23, with the net asset value at $341.14. The fund launched on 26 January 2004 and tracks a healthcare sector index of the U.S. market.

Fund fact

Detail

Market price (6 November 2026)

$341.23

Day change

+$0.03 (+0.01%)

Net asset value

$341.14

Expense ratio

0.09% a year

30-day SEC yield

1.16%

Fund net assets

$23.7 billion

Sub-Sector Profile

Pharmaceuticals account for 33.20 per cent of the portfolio, followed by biotechnology at 24.20 per cent, health care equipment at 13.50 per cent and life sciences tools and services at 10.60 per cent. Managed health care accounts for 7.20 per cent, with distributors, services and supplies making up the rest.

Drug developers therefore form close to 60 per cent of the portfolio, so clinical trial outcomes, regulatory decisions and Patent timelines at those companies can influence the fund's unit price.

Leading Holdings

Eli Lilly is the largest holding at 12.93 per cent, followed by Johnson and Johnson at 8.78 per cent, AbbVie at 6.45 per cent and Merck at 5.01 per cent. UnitedHealth Group, Thermo Fisher Scientific, Amgen, Gilead Sciences, Abbott Laboratories and Pfizer complete the top ten.

The top ten holdings make up a substantial share of the fund, and the top two alone account for more than a fifth of assets. The portfolio contains 412 stocks in total.

Income and Costs

The 30-day SEC Yield is 1.16 per cent, and the expense ratio is 0.09 per cent a year, which equates to about $9 on a $10,000 holding. The fund pays distributions quarterly.

Net Assets were reported at $23.7 billion at 31 October 2026. Units trade on the exchange, and the price closely tracked net asset value on 6 November.

Final Word

The Vanguard Health Care ETF offers exposure to 412 U.S. healthcare companies, with pharmaceutical and biotechnology businesses making up almost 60 per cent of the portfolio. The market price was little changed on 6 November, and the expense ratio is 0.09 per cent a year. Clinical, regulatory and pricing developments at the largest drug makers are the factors that will matter most to the fund's direction.